IonQ, Inc.

New York Stock Exchange
Back to all articles
Somewhat Bullish +45

IONQ INC. Discloses $110,000 Lobbying Expenditures in Q2 2026

🏛️ IonQ Inc. reported $110,000 in lobbying expenditures for Q2 2026 focused on FY2027 appropriations and quantum computing legislation.

📈 Defiance ETFs, LLC increased its IonQ holdings by over 1,155% by adding 8,929,328 shares in the most recent quarter.

📉 Insider trading shows a net sell trend with seven sales against one purchase, led by Robert T. Cardillo selling 7,665 shares.

🏦 Major institutions including Two Sigma Investments and Goldman Sachs Group adjusted their positions during the reporting period.

💰 Analyst price targets for IonQ range from $35 to $100 with a median target of $65 set by eight analysts over six months.

🗳️ Congressional trading activity was limited, recording only one purchase and no sales among members of Congress in the last six months.

Bullish Signals
  • Institutional accumulation is strong, evidenced by Defiance ETFs, LLC adding 8.9 million shares (over 1,155% increase) alongside activity from Two Sigma Investments and Goldman Sachs Group.
  • Analyst consensus remains bullish with a median price target of $65, supported by ambitious targets of $70 from Northland Capital Markets and $100 from Rosenblatt.
  • Strategic lobbying spend of $110,000 in Q2 2026 indicates active engagement to secure favorable fiscal year 2027 appropriations and quantum computing policy support.
Risk Factors
  • Insider trading activity shows a net selling trend with seven transactions resulting in sales versus only one purchase over the past six months.
  • Significant insider offloading includes Robert T. Cardillo selling 7,665 shares for $315,934 and John W. Raymond selling 6,615 shares for $303,215.
Full Analysis
IonQ Inc. disclosed $110,000 in lobbying expenditures for the second quarter of 2026 under the Lobbying Disclosure Act. The company's efforts are primarily directed toward securing fiscal year 2027 appropriations and influencing legislation related to quantum computing, specifically aligning with ongoing congressional discussions regarding the National Defense Authorization Act (NDAA). Institutional investor activity remains robust, with 325 institutions increasing their holdings while 269 reduced theirs in the most recent quarter. A standout move came from Defiance ETFs, LLC, which added 8,929,328 shares to its portfolio, representing an increase of over 1,155%. Other major financial players, including Two Sigma Investments and Goldman Sachs Group, also adjusted their positions during this period. Insider trading data reveals a net selling trend among IonQ executives over the past six months. While William J. Teuber purchased 3,000 shares for approximately $115,155, other insiders like Robert T. Cardillo and John W. Raymond executed significant sales totaling over $600,000 combined. Analyst sentiment is mixed but generally bullish, with eight analysts issuing price targets ranging from a low of $35 to a high of $100, setting a median target of $65. The article highlights IonQ's strategic positioning through government relations and capital market engagement as the company navigates a crucial phase for quantum computing development. The combination of substantial lobbying spend, heavy institutional accumulation by specific ETFs, and varied analyst price targets suggests active market interest in IonQ's future prospects and regulatory environment.